Investing
FTC Commissioners yet to meet on Amgen-Horizon deal – CNBC
© Reuters. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/
(Reuters) – Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen (NASDAQ:)’s acquisition of Horizon Therapeutics (NASDAQ:), CNBC reported on Tuesday.
The news comes a day after reports that the FTC is expected to file a lawsuit as early as Tuesday to block the $27.8 billion deal.
Read the full article here
-
Side Hustles7 days ago
Microsoft Is About to Begin Job Cuts. Here’s Why.
-
Make Money6 days ago
10 Critical Questions to Ask Your Financial Advisor Now
-
Make Money5 days ago
10 Ways to Make Money As a Graphic Designer
-
Personal Finance4 days ago
If you are 60 years old, new 401(k) rules could save you money
-
Investing7 days ago
What CMOs Need to Know About AI Adoption in Marketing Teams
-
Investing6 days ago
Airbus keeps top spot with 766 jet deliveries in 2024 By Reuters
-
Investing5 days ago
Could Easier Cancellations Build Customer Loyalty?
-
Passive Income7 days ago
3 AI Leadership Lessons for 2025